UK Spy Chief Warns of Moment of Consequence as West Faces Mounting Threats from Russia and China Gilead Sciences GILD Ranked Among Wall Streets Most Profitable Stock Picks with 31 Net Margin and 24 Upside Potential Oils Supply Crunch May Face Delays Amid Economic Uncertainty Powell Vows to Avoid Shadow Chair Role as Potential Warsh Era Creates Historic Fed Dynamic Oregons Gas Tax Defeat Political Fallout and Implications for Infrastructure Funding Caribbean Property Rights Strain as Foreign Investment Reshapes Coastal Access CF Industries Q1 2026 Earnings EPS Beats Expectations Amidst Stable Operations BOBS Q1 2026 Earnings EPS Surges Past Estimates Shares Dip Despite Strong Beat OCC Q1 2026 Earnings Narrowed Loss and Market Sentiment Boost Drive Stock Surge 908 Devices MASS Q1 2026 Earnings EPS Misses Estimates as Stock Edges Higher BG Q1 2026 Earnings Earnings Surge 103 Above Estimates as Agribusiness Strength Outpaces Expectations TECX Q1 2026 Earnings EPS Miss as PreCommercial Biotech Advances Pipeline BioNTech BNTX Edges Higher Testing Key Technical Levels Amid Vaccine Market Shifts DigitalBridge Group DBRG Holds Steady Near Support as Volume Signals Caution Stardust Power SDST Gains 5 as Shares Test Key Resistance Levels Restaurant Brands International QSR Dips 114 as Support Levels Come into Focus Southside Bancshares SBSI Edges Lower Amid Quiet Trading Support Holds Near 3116 SP 500 Edges Higher as Healthcare and Tech Lead Communication Services Dips ACMR Q1 2026 Earnings Strong EPS Beat Drives Stock Higher bioAffinity Technologies BIAF Holds Near Support as Minimal Decline Reflects Cautious Trading Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues VEON Q1 2026 Earnings EPS Surpasses Estimates as Digital Transformation Gains Traction CVNA Q1 2026 Earnings EPS Surprises to the Upside Stock Rallies CTSO Q1 2026 Earnings Loss Widens as EPS Misses Estimates Stock Gains 642 CMMB Q1 2026 Earnings Missed EPS Estimates but Stock Gains on Continued Pipeline Progress TAL Q1 2026 Earnings Massive EPS Beat Amidst Revenue Uncertainty Immunome Inc IMNM Q1 2026 Earnings SmallerThanExpected Loss as Biotech Advances Pipeline